Torrent Pharmaceuticals Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹4,197.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 27.07 per cent from ₹3,303.00 crore. This corresponds to a year-on-year *(YoY) growth of 41.84 per cent.
Operating Profit
Operating Profit stands at ₹1,290.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 19.67 per cent from ₹1,078.00 crore. This corresponds to a year-on-year *(YoY) growth of 37.23 per cent.
PBDT
PBDT stands at ₹1,037.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 1.67 per cent from ₹1,020.00 crore. This corresponds to a year-on-year *(YoY) growth of 19.75 per cent.
Profit Before Tax
Profit Before Tax stands at ₹529.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 35.01 per cent from ₹814.00 crore. This corresponds to a year-on-year *(YoY) decline of 20.45 per cent.
Net Profit
Net Profit stands at ₹364.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 42.68 per cent from ₹635.00 crore. This represents a 26.91 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Torrent Pharmaceuticals Ltd News
Torrent Pharmaceuticals Ltd Earnings
- YOY
- QOQ
Torrent Pharmaceuticals Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Torrent Pharmaceuticals Ltd Research Reports
Torrent Pharmaceuticals Ltd Financial Reports
Torrent Pharmaceuticals Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Torrent Pharma. | 0.56% | 4.55% | 10.00% | 20.49% | 20.57% | 46.02% |
| Sun Pharma.Inds. | -0.66% | 1.99% | 6.40% | 11.05% | 8.04% | 13.76% |
| Divi's Lab. | -1.07% | 3.59% | 4.01% | 15.24% | 2.75% | -2.23% |
| Cipla | -1.51% | -0.55% | 4.38% | 19.18% | -0.79% | -2.63% |
| Zydus Lifesci. | 0.35% | 3.97% | 6.02% | 29.31% | 27.03% | 17.28% |
| Lupin | -0.01% | 3.90% | 10.53% | 8.56% | 13.67% | 29.56% |
Company Info
Company Information
Chairman/ED & CEO : Samir Mehta
ED / MD / Promoter : Aman Mehta
Non-Exec & Non-Independent Dir : Jindal Mehta
Lead Independent Non Executive Director : Manish Choksi
Independent Non Exe. Director : Ameera Sushil Shah
Independent Non Exe. Director : Nayantara Bali
Independent Non Exe. Director : Nikhil Khattau
Company Sec. & Compli. Officer : Chintan M. Trivedi
Chairman Emeritus : Sudhir Mehta